CHARLOTTE C SUN

Concepts (507)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
79
2024
4790
4.250
Why?
Cystadenocarcinoma, Serous
23
2022
496
3.070
Why?
Genital Neoplasms, Female
23
2022
790
2.440
Why?
Peritoneal Neoplasms
15
2022
859
1.900
Why?
Uterine Cervical Neoplasms
24
2022
1900
1.640
Why?
Endometrial Neoplasms
21
2022
1388
1.200
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
10
2019
481
1.080
Why?
Patient Preference
3
2019
228
1.060
Why?
Patient Satisfaction
9
2019
919
1.010
Why?
Neoplasms, Cystic, Mucinous, and Serous
4
2017
107
0.920
Why?
Aromatase Inhibitors
3
2022
311
0.810
Why?
Maintenance Chemotherapy
2
2024
224
0.730
Why?
Cytoreduction Surgical Procedures
9
2023
510
0.700
Why?
Female
165
2024
148865
0.700
Why?
Antineoplastic Agents, Hormonal
5
2020
841
0.680
Why?
Quality of Life
18
2024
4774
0.660
Why?
Middle Aged
124
2024
90294
0.660
Why?
Health Knowledge, Attitudes, Practice
4
2015
1231
0.650
Why?
Genetic Testing
8
2019
1697
0.630
Why?
Adult
111
2024
81946
0.610
Why?
Aged
98
2024
73338
0.600
Why?
Hysterectomy
12
2019
651
0.590
Why?
Health Status
2
2014
631
0.580
Why?
Endometrial Hyperplasia
4
2020
124
0.580
Why?
Healthcare Disparities
4
2018
657
0.570
Why?
Spirituality
3
2014
129
0.550
Why?
Carcinoma, Endometrioid
7
2020
327
0.550
Why?
Carcinoma
8
2018
2609
0.540
Why?
Patient Acceptance of Health Care
5
2017
599
0.540
Why?
Medicare
6
2024
925
0.530
Why?
Ovariectomy
6
2018
369
0.510
Why?
Humans
168
2024
270631
0.500
Why?
Peritoneum
3
2022
150
0.490
Why?
Watchful Waiting
1
2017
293
0.480
Why?
Internal-External Control
4
2017
108
0.480
Why?
Anxiety
7
2016
1236
0.470
Why?
Young Adult
35
2020
22201
0.470
Why?
Health Services Accessibility
4
2024
822
0.460
Why?
Gynecologic Surgical Procedures
6
2019
380
0.450
Why?
Vulnerable Populations
1
2015
187
0.440
Why?
Fallopian Tube Neoplasms
5
2018
154
0.430
Why?
Aged, 80 and over
49
2024
30994
0.420
Why?
Neoplasm Grading
10
2020
1822
0.400
Why?
Perception
2
2013
349
0.400
Why?
Religion
2
2013
95
0.390
Why?
Medicaid
5
2024
305
0.380
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2024
16664
0.370
Why?
Retrospective Studies
49
2024
39811
0.370
Why?
Advance Care Planning
3
2017
93
0.360
Why?
Neoplasm Staging
27
2021
14009
0.360
Why?
Adenocarcinoma
14
2018
7913
0.350
Why?
Adenocarcinoma, Clear Cell
4
2017
176
0.350
Why?
Sexuality
2
2006
38
0.340
Why?
Genes, BRCA2
6
2017
321
0.330
Why?
Disease-Free Survival
15
2023
10258
0.330
Why?
Neoplasms, Glandular and Epithelial
4
2017
517
0.330
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2024
518
0.330
Why?
Genes, BRCA1
6
2017
396
0.320
Why?
Insurance Coverage
4
2024
275
0.320
Why?
Primary Health Care
1
2015
831
0.320
Why?
Cystadenocarcinoma, Papillary
3
2022
82
0.320
Why?
United States
26
2024
15834
0.320
Why?
Surveys and Questionnaires
15
2019
5914
0.320
Why?
Attitude of Health Personnel
2
2013
898
0.310
Why?
Medical Oncology
3
2011
1463
0.310
Why?
Practice Patterns, Physicians'
3
2018
1300
0.310
Why?
Patient Protection and Affordable Care Act
3
2024
107
0.300
Why?
Attitude to Health
3
2019
434
0.300
Why?
Neoplasm Recurrence, Local
15
2022
10383
0.300
Why?
Risk Reduction Behavior
4
2018
209
0.300
Why?
Uterine Neoplasms
4
2016
576
0.290
Why?
Burnout, Professional
1
2011
224
0.290
Why?
Tamoxifen
3
2020
875
0.290
Why?
Neoadjuvant Therapy
14
2023
5231
0.290
Why?
Early Detection of Cancer
6
2016
1339
0.280
Why?
BRCA2 Protein
3
2018
379
0.280
Why?
Combined Modality Therapy
7
2014
9039
0.270
Why?
CA-125 Antigen
3
2020
228
0.270
Why?
Obesity
6
2019
2904
0.270
Why?
Digestive System Surgical Procedures
2
2020
275
0.270
Why?
Cohort Studies
17
2021
9471
0.270
Why?
Salpingectomy
2
2018
46
0.260
Why?
Laparoscopy
5
2021
1301
0.260
Why?
SEER Program
9
2022
1047
0.260
Why?
BRCA1 Protein
3
2018
525
0.260
Why?
Decision Making
4
2011
1249
0.260
Why?
Smoking
2
2014
2555
0.250
Why?
Pancreaticoduodenectomy
7
2010
706
0.250
Why?
Uterine Hemorrhage
2
2016
64
0.250
Why?
Postoperative Complications
12
2024
5672
0.240
Why?
Insurance Claim Review
2
2022
73
0.240
Why?
Medically Uninsured
2
2024
105
0.240
Why?
Bevacizumab
3
2024
966
0.240
Why?
Vomiting
3
2014
362
0.230
Why?
Platinum Compounds
3
2017
129
0.220
Why?
Survival Rate
16
2018
12518
0.220
Why?
Carcinosarcoma
2
2017
146
0.210
Why?
Palliative Care
5
2015
2173
0.210
Why?
Nausea
4
2015
540
0.200
Why?
Symptom Assessment
2
2015
272
0.200
Why?
Genetic Counseling
4
2018
417
0.200
Why?
Mental Health
2
2017
413
0.200
Why?
Lymph Node Excision
9
2018
2062
0.200
Why?
Body Mass Index
7
2020
2238
0.200
Why?
Health Care Costs
5
2019
698
0.190
Why?
Terminal Care
2
2017
465
0.190
Why?
Texas
9
2016
6436
0.190
Why?
Cost Sharing
1
2021
7
0.190
Why?
Chemotherapy, Adjuvant
10
2023
4000
0.190
Why?
Carcinoma, Squamous Cell
4
2014
5588
0.190
Why?
Schools
1
2022
238
0.180
Why?
Adaptation, Psychological
3
2014
787
0.180
Why?
Health Expenditures
2
2021
202
0.180
Why?
Mutation
9
2022
15911
0.180
Why?
Intrauterine Devices, Medicated
1
2020
38
0.180
Why?
Levonorgestrel
1
2020
53
0.180
Why?
Deoxycytidine
5
2017
1389
0.180
Why?
Time-to-Treatment
1
2022
307
0.170
Why?
Prognosis
17
2018
22473
0.170
Why?
Drug-Related Side Effects and Adverse Reactions
1
2004
625
0.170
Why?
Pain Measurement
3
2014
1018
0.170
Why?
Live Birth
1
2019
59
0.160
Why?
Genetic Predisposition to Disease
6
2019
5775
0.160
Why?
Fertility Preservation
2
2019
151
0.160
Why?
Pregnancy Rate
1
2019
61
0.160
Why?
Hospitals, County
1
2018
31
0.160
Why?
Body Weight
3
2016
1311
0.160
Why?
Patient Reported Outcome Measures
3
2022
864
0.160
Why?
Gynecology
2
2012
235
0.160
Why?
Age Factors
9
2018
5464
0.160
Why?
Neoplastic Syndromes, Hereditary
2
2011
232
0.160
Why?
Receptors, Progesterone
4
2020
1604
0.160
Why?
Advance Directives
2
2016
89
0.160
Why?
Patient Participation
3
2017
453
0.160
Why?
Ovary
3
2015
688
0.160
Why?
Pancreatic Neoplasms
7
2010
5254
0.160
Why?
Reproductive Techniques, Assisted
1
2019
95
0.150
Why?
Risk Management
1
2019
112
0.150
Why?
Adolescent
19
2019
32719
0.150
Why?
Antimetabolites, Antineoplastic
3
2013
1347
0.150
Why?
Prospective Studies
11
2018
13412
0.150
Why?
Antineoplastic Agents
13
2020
14616
0.150
Why?
Patient Outcome Assessment
1
2019
245
0.150
Why?
Sentinel Lymph Node
2
2018
235
0.150
Why?
Neoplasms
5
2024
15909
0.150
Why?
Follow-Up Studies
8
2017
15204
0.150
Why?
Pelvic Exenteration
1
2018
112
0.140
Why?
Intra-Abdominal Fat
1
2018
94
0.140
Why?
Cost-Benefit Analysis
7
2021
965
0.140
Why?
Psychometrics
3
2017
970
0.140
Why?
Hereditary Breast and Ovarian Cancer Syndrome
1
2017
26
0.140
Why?
Blood Loss, Surgical
3
2008
294
0.140
Why?
Postmenopause
2
2016
377
0.140
Why?
Medroxyprogesterone Acetate
1
2017
49
0.140
Why?
Risk Factors
14
2023
17875
0.140
Why?
Leuprolide
1
2017
66
0.140
Why?
Time Factors
12
2021
13017
0.140
Why?
Vaginal Discharge
1
2016
9
0.140
Why?
Length of Stay
5
2019
2004
0.140
Why?
Lymphatic Vessels
1
2017
138
0.130
Why?
Colorectal Neoplasms
3
2022
3707
0.130
Why?
Receptors, Estrogen
3
2020
2171
0.130
Why?
Breast Neoplasms
9
2010
16204
0.130
Why?
Surgical Wound Infection
2
2017
480
0.130
Why?
Adiposity
1
2018
238
0.130
Why?
Automobiles
1
2015
10
0.130
Why?
Obesity, Morbid
2
2017
234
0.130
Why?
Health Services Needs and Demand
1
2018
246
0.130
Why?
Hospitals
1
2019
482
0.130
Why?
Survivors
2
2015
1022
0.130
Why?
Vaginal Neoplasms
2
2010
152
0.130
Why?
Lymph Nodes
4
2017
3078
0.130
Why?
Safety-net Providers
1
2015
55
0.120
Why?
Health Behavior
1
2019
600
0.120
Why?
Poverty
1
2018
481
0.120
Why?
Physicians
3
2013
852
0.120
Why?
Intestinal Obstruction
1
2017
223
0.120
Why?
Mind-Body Therapies
1
2014
29
0.120
Why?
Antibiotic Prophylaxis
1
2016
214
0.120
Why?
Documentation
1
2016
213
0.120
Why?
Taxoids
4
2020
1015
0.120
Why?
Health Literacy
1
2015
117
0.120
Why?
Delayed Diagnosis
1
2015
147
0.120
Why?
Treatment Outcome
16
2020
33722
0.120
Why?
Fear
1
2015
259
0.110
Why?
Cystadenoma, Serous
1
2013
31
0.110
Why?
Breast
1
2020
1370
0.110
Why?
Piperazines
4
2021
2145
0.110
Why?
Holistic Health
1
2013
13
0.110
Why?
Sentinel Lymph Node Biopsy
2
2018
1458
0.110
Why?
Carcinoma, Adenosquamous
3
2009
107
0.110
Why?
Leiomyoma
1
2014
161
0.110
Why?
ras Proteins
2
2015
804
0.110
Why?
Calcinosis
1
2016
426
0.110
Why?
Self-Assessment
1
2013
89
0.110
Why?
Erythrocyte Transfusion
1
2014
205
0.110
Why?
Bridged-Ring Compounds
2
2020
190
0.110
Why?
Clinical Competence
4
2011
1323
0.110
Why?
Neoplasms, Multiple Primary
3
2005
556
0.100
Why?
Metformin
1
2016
393
0.100
Why?
Hospice Care
1
2014
162
0.100
Why?
Fluorouracil
3
2013
1989
0.100
Why?
Triazoles
1
2017
627
0.100
Why?
Hypoglycemic Agents
1
2016
598
0.100
Why?
Scientific Misconduct
1
2012
20
0.100
Why?
Delivery of Health Care
3
2022
854
0.100
Why?
Blood Transfusion
1
2015
581
0.100
Why?
Preoperative Care
2
2008
1565
0.100
Why?
Mastectomy
3
2009
1553
0.100
Why?
Antibodies, Monoclonal, Humanized
1
2023
3408
0.100
Why?
Nitriles
1
2017
938
0.100
Why?
Oncology Service, Hospital
1
2012
49
0.100
Why?
Robotic Surgical Procedures
2
2017
535
0.100
Why?
Cisplatin
4
2013
2496
0.100
Why?
Venous Thromboembolism
1
2017
376
0.100
Why?
PTEN Phosphohydrolase
1
2016
1012
0.100
Why?
Frozen Sections
2
2018
111
0.100
Why?
Kaplan-Meier Estimate
7
2018
6253
0.100
Why?
Patient Education as Topic
2
2008
744
0.090
Why?
Suicide, Assisted
1
2011
21
0.090
Why?
Triple Negative Breast Neoplasms
1
2021
1388
0.090
Why?
Neoplasms, Germ Cell and Embryonal
1
2014
347
0.090
Why?
Religion and Medicine
1
2011
46
0.090
Why?
Professional-Patient Relations
1
2011
114
0.090
Why?
Serotonin Antagonists
1
2010
50
0.090
Why?
Antibodies, Monoclonal
1
2023
4480
0.090
Why?
Health Personnel
2
2013
649
0.090
Why?
Ethics Consultation
1
2011
36
0.090
Why?
Quinuclidines
1
2010
47
0.090
Why?
Preimplantation Diagnosis
1
2010
37
0.090
Why?
Cancer Survivors
1
2018
744
0.090
Why?
Proto-Oncogene Proteins B-raf
3
2015
1335
0.090
Why?
Registries
3
2015
2209
0.090
Why?
Workload
1
2012
195
0.090
Why?
Life Style
1
2014
617
0.090
Why?
Prevalence
3
2014
3401
0.090
Why?
Isoquinolines
1
2010
125
0.090
Why?
Premenopause
2
2014
138
0.090
Why?
Databases, Factual
5
2019
2250
0.090
Why?
Geriatrics
1
2010
90
0.090
Why?
Case-Control Studies
6
2024
6238
0.090
Why?
Fallopian Tubes
1
2010
128
0.090
Why?
Cost of Illness
1
2013
503
0.090
Why?
Physicians, Primary Care
1
2010
102
0.080
Why?
Sarcoma, Endometrial Stromal
1
2009
20
0.080
Why?
CA-19-9 Antigen
1
2010
155
0.080
Why?
Pelvic Bones
1
2010
102
0.080
Why?
Kidney
1
2018
2119
0.080
Why?
Radiotherapy, Adjuvant
5
2019
2271
0.080
Why?
Phthalazines
2
2021
262
0.080
Why?
Communication
2
2013
835
0.080
Why?
Primary Prevention
1
2010
233
0.080
Why?
Education, Medical, Continuing
1
2011
230
0.080
Why?
Information Dissemination
1
2011
266
0.080
Why?
Hormone Antagonists
1
2009
115
0.080
Why?
Mifepristone
1
2009
180
0.080
Why?
Social Class
2
2007
323
0.080
Why?
Intestinal Perforation
1
2009
107
0.080
Why?
Referral and Consultation
1
2014
930
0.080
Why?
Ki-67 Antigen
2
2020
676
0.080
Why?
Quality-Adjusted Life Years
3
2018
236
0.080
Why?
Fatigue
3
2015
1278
0.080
Why?
Proto-Oncogene Proteins
2
2015
2618
0.070
Why?
Adaptor Proteins, Signal Transducing
4
2020
1469
0.070
Why?
Radiotherapy
3
2010
1857
0.070
Why?
Neoplasms, Squamous Cell
1
2008
84
0.070
Why?
Fellowships and Scholarships
1
2012
411
0.070
Why?
Male
18
2024
128316
0.070
Why?
Gene Expression
3
2020
3641
0.070
Why?
Physician-Patient Relations
2
2011
734
0.070
Why?
Obstetrics
1
2010
243
0.070
Why?
MutL Protein Homolog 1
3
2014
206
0.070
Why?
MutS Homolog 2 Protein
3
2014
179
0.070
Why?
Robotics
1
2011
365
0.070
Why?
Emergency Service, Hospital
1
2015
1245
0.070
Why?
Marital Therapy
1
2006
5
0.070
Why?
Menopause, Premature
1
2007
16
0.070
Why?
Sex Counseling
1
2006
16
0.070
Why?
Fractures, Bone
1
2010
310
0.070
Why?
Salpingostomy
1
2006
8
0.070
Why?
Adenocarcinoma, Mucinous
1
2010
442
0.070
Why?
Comorbidity
3
2023
2392
0.070
Why?
Patient Safety
1
2012
612
0.070
Why?
Models, Economic
2
2021
102
0.070
Why?
Sexual Behavior
2
2005
313
0.070
Why?
Survival Analysis
8
2014
9290
0.070
Why?
Pyrimidines
3
2021
3666
0.070
Why?
Neoplasm Invasiveness
4
2020
4048
0.060
Why?
Drug Resistance, Neoplasm
5
2020
5403
0.060
Why?
Biomarkers, Tumor
4
2020
10701
0.060
Why?
Markov Chains
3
2011
185
0.060
Why?
Disease Progression
1
2017
6853
0.060
Why?
Social Support
4
2013
590
0.060
Why?
Carcinoma, Large Cell
1
2005
98
0.060
Why?
Gene Amplification
2
2006
766
0.060
Why?
Tomography, X-Ray Computed
3
2016
7782
0.060
Why?
Randomized Controlled Trials as Topic
3
2020
2650
0.060
Why?
Carboplatin
3
2017
879
0.060
Why?
Clinical Trials, Phase II as Topic
2
2009
690
0.060
Why?
Alopecia
1
2004
123
0.060
Why?
Vacuum
1
2004
43
0.060
Why?
Mesenteric Veins
1
2004
83
0.060
Why?
Uterus
1
2009
798
0.060
Why?
DNA Mutational Analysis
3
2015
2357
0.060
Why?
Organoplatinum Compounds
2
2020
704
0.060
Why?
Medical Records
3
2014
442
0.060
Why?
Anorexia
2
2015
147
0.060
Why?
Proportional Hazards Models
3
2023
5100
0.060
Why?
Genes, erbB-2
1
2004
228
0.060
Why?
Progestins
2
2019
92
0.060
Why?
Health Surveys
2
2019
399
0.060
Why?
Proto-Oncogene Proteins c-abl
1
2003
84
0.050
Why?
Papillomavirus Vaccines
1
2006
197
0.050
Why?
Diagnostic Errors
1
2008
517
0.050
Why?
Perioperative Care
2
2019
447
0.050
Why?
Viral Vaccines
1
2006
363
0.050
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
153
0.050
Why?
Patient Selection
1
2010
2026
0.050
Why?
Interviews as Topic
1
2004
521
0.050
Why?
Carcinoma, Small Cell
1
2005
427
0.050
Why?
Papillomaviridae
1
2006
636
0.050
Why?
Severity of Illness Index
1
2013
4374
0.050
Why?
Monte Carlo Method
3
2011
704
0.050
Why?
Immunohistochemistry
6
2013
7663
0.050
Why?
Portal Vein
1
2004
363
0.050
Why?
Radiation Injuries
1
2010
1470
0.050
Why?
Membrane Proteins
3
2020
2929
0.050
Why?
Socioeconomic Factors
2
2017
1264
0.050
Why?
Protein-Tyrosine Kinases
2
2006
1838
0.050
Why?
Proto-Oncogene Proteins c-kit
1
2003
484
0.050
Why?
Minimally Invasive Surgical Procedures
2
2017
509
0.050
Why?
Pancreatectomy
2
2020
696
0.050
Why?
Paclitaxel
3
2017
2100
0.050
Why?
Insurance, Health, Reimbursement
1
2021
67
0.040
Why?
Ostomy
1
2020
19
0.040
Why?
Pilot Projects
3
2018
2846
0.040
Why?
Depression
3
2015
1731
0.040
Why?
Retinal Dehydrogenase
1
2020
85
0.040
Why?
Logistic Models
3
2016
3447
0.040
Why?
Incidence
4
2016
5821
0.040
Why?
Predictive Value of Tests
4
2013
4962
0.040
Why?
Reproducibility of Results
3
2017
6191
0.040
Why?
Response Evaluation Criteria in Solid Tumors
1
2020
164
0.040
Why?
Neoplasm Proteins
2
2013
3344
0.040
Why?
Neoplasms, Second Primary
2
2005
1387
0.040
Why?
Splenectomy
1
2020
168
0.040
Why?
Deductibles and Coinsurance
1
2019
10
0.040
Why?
Data Collection
2
2013
608
0.040
Why?
Machine Learning
1
2022
361
0.040
Why?
Pregnancy
4
2019
8117
0.040
Why?
Internship and Residency
1
2010
1443
0.040
Why?
Cyclophosphamide
3
2017
3242
0.040
Why?
Diaphragm
1
2020
187
0.040
Why?
Wound Healing
1
2004
764
0.040
Why?
Bayes Theorem
1
2023
1058
0.040
Why?
Lymphatic Metastasis
4
2010
4963
0.040
Why?
Sexual Health
1
2018
17
0.040
Why?
Dose-Response Relationship, Drug
2
2005
5070
0.040
Why?
Diagnostic Tests, Routine
1
1999
167
0.040
Why?
Clinical Laboratory Techniques
1
1999
200
0.040
Why?
Siblings
1
2019
318
0.040
Why?
Proto-Oncogene Proteins p21(ras)
2
2015
1401
0.040
Why?
Pyrroles
1
2021
589
0.040
Why?
Wnt Signaling Pathway
1
2020
445
0.040
Why?
Mammaplasty
1
2004
714
0.040
Why?
Ultrasonography, Interventional
1
2000
424
0.040
Why?
Body Image
1
2018
123
0.040
Why?
Intercellular Signaling Peptides and Proteins
1
2020
659
0.040
Why?
Hysterectomy, Vaginal
1
2017
35
0.040
Why?
Algorithms
2
2022
3900
0.040
Why?
Carcinoma in Situ
1
2000
489
0.030
Why?
Coloring Agents
1
2017
233
0.030
Why?
Receptors, Cell Surface
1
2020
904
0.030
Why?
Decision Support Techniques
2
2018
601
0.030
Why?
ErbB Receptors
1
2005
2376
0.030
Why?
Nuclear Proteins
3
2014
3438
0.030
Why?
Indocyanine Green
1
2017
125
0.030
Why?
Pain
2
2015
1698
0.030
Why?
Sensitivity and Specificity
3
2013
5171
0.030
Why?
Adiponectin
1
2016
143
0.030
Why?
ROC Curve
1
1999
1249
0.030
Why?
Linear Models
1
2019
1097
0.030
Why?
Clinical Trials as Topic
1
2006
3844
0.030
Why?
Intestines
1
2020
735
0.030
Why?
Hospices
1
2015
50
0.030
Why?
Parity
2
2006
136
0.030
Why?
Laparotomy
1
2017
234
0.030
Why?
Attitude to Death
1
2016
102
0.030
Why?
Weight Loss
1
2019
629
0.030
Why?
Stem Cell Transplantation
1
2002
1414
0.030
Why?
MAP Kinase Signaling System
1
2020
885
0.030
Why?
Niacinamide
1
2017
427
0.030
Why?
Receptor, ErbB-2
1
2005
2651
0.030
Why?
Propensity Score
1
2018
771
0.030
Why?
Models, Statistical
1
2021
1185
0.030
Why?
Health Care Surveys
2
2008
418
0.030
Why?
Needs Assessment
2
2008
237
0.030
Why?
DNA-Binding Proteins
3
2014
5001
0.030
Why?
Computer Simulation
2
2010
1570
0.030
Why?
Population Surveillance
1
2018
645
0.030
Why?
Capecitabine
2
2006
390
0.030
Why?
Mismatch Repair Endonuclease PMS2
1
2014
49
0.030
Why?
Constipation
1
2015
187
0.030
Why?
Risk Adjustment
1
2014
74
0.030
Why?
Imatinib Mesylate
2
2012
1690
0.030
Why?
Sleep Initiation and Maintenance Disorders
1
2015
140
0.030
Why?
General Surgery
2
2007
331
0.030
Why?
Hospital Mortality
1
2019
1232
0.030
Why?
Hepatectomy
1
2020
1015
0.030
Why?
Melanoma
1
2010
5594
0.030
Why?
Phenylurea Compounds
1
2017
600
0.030
Why?
Culture
1
2013
104
0.030
Why?
Tumor Burden
1
2019
2033
0.030
Why?
MAP Kinase Kinase Kinases
1
2013
188
0.030
Why?
DNA Repair Enzymes
1
2014
237
0.030
Why?
Benzamides
2
2012
1878
0.030
Why?
Longitudinal Studies
1
2018
2056
0.030
Why?
Stomatitis
1
2013
193
0.030
Why?
Cross-Sectional Studies
1
2022
4491
0.030
Why?
Child
4
2019
30517
0.030
Why?
Psychotherapy
1
2014
249
0.030
Why?
Demography
1
2013
432
0.020
Why?
Classification
1
2011
39
0.020
Why?
Immunoenzyme Techniques
1
2014
1189
0.020
Why?
Adenosine Triphosphatases
1
2014
427
0.020
Why?
Hyperplasia
1
2013
565
0.020
Why?
Cancer Care Facilities
2
2008
907
0.020
Why?
Cell Death
1
2013
686
0.020
Why?
DNA Mismatch Repair
1
2013
283
0.020
Why?
Cognition
1
2017
968
0.020
Why?
Germ-Line Mutation
2
2007
1101
0.020
Why?
Positron Emission Tomography Computed Tomography
1
2017
880
0.020
Why?
Research Report
1
2012
136
0.020
Why?
Genomics
1
2022
2835
0.020
Why?
Heterozygote
1
2014
1056
0.020
Why?
Drug Administration Schedule
2
2007
3529
0.020
Why?
Benzimidazoles
1
2013
439
0.020
Why?
Pubic Bone
1
2010
16
0.020
Why?
Estrogen Antagonists
1
2011
188
0.020
Why?
Life Expectancy
1
2010
129
0.020
Why?
Acetabulum
1
2010
41
0.020
Why?
In Situ Hybridization, Fluorescence
2
2006
2308
0.020
Why?
Diarrhea
1
2013
716
0.020
Why?
Quality Improvement
1
2017
912
0.020
Why?
Intraoperative Complications
1
2012
288
0.020
Why?
Sacrum
1
2010
138
0.020
Why?
Biomarkers
1
2020
5060
0.020
Why?
Mass Screening
1
2017
1547
0.020
Why?
State Health Plans
1
2008
8
0.020
Why?
Stress, Psychological
1
2015
1044
0.020
Why?
Risk Assessment
2
2011
6766
0.020
Why?
DNA, Neoplasm
1
2013
1958
0.020
Why?
Program Evaluation
1
2010
600
0.020
Why?
Neoplasms, Hormone-Dependent
1
2009
347
0.020
Why?
Apoptosis Regulatory Proteins
1
2010
622
0.020
Why?
Protein Kinase Inhibitors
2
2013
4960
0.020
Why?
Pedigree
1
2011
2042
0.020
Why?
Bone Density
1
2010
467
0.020
Why?
Retroperitoneal Space
1
2006
156
0.020
Why?
Tumor Cells, Cultured
1
2013
5759
0.020
Why?
DNA Copy Number Variations
1
2013
1556
0.020
Why?
Neoplasm Metastasis
2
2006
5309
0.020
Why?
Pregnancy Complications
1
2011
562
0.020
Why?
Fatal Outcome
1
2008
824
0.020
Why?
Microsatellite Repeats
1
2007
628
0.020
Why?
Menstruation Disturbances
1
2005
22
0.020
Why?
Mixed Tumor, Mullerian
1
2004
37
0.010
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
231
0.010
Why?
Chemoradiotherapy
1
2013
2027
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2010
2474
0.010
Why?
High-Throughput Nucleotide Sequencing
1
2013
2357
0.010
Why?
Occlusive Dressings
1
2004
14
0.010
Why?
Myometrium
1
2004
82
0.010
Why?
Intraoperative Period
1
2004
251
0.010
Why?
Polycystic Ovary Syndrome
1
2005
73
0.010
Why?
Decision Trees
1
2004
181
0.010
Why?
Cloning, Molecular
1
2006
1431
0.010
Why?
Melphalan
1
2007
875
0.010
Why?
Treatment Failure
1
2007
1428
0.010
Why?
DNA Methylation
1
2014
2766
0.010
Why?
Patient Care Team
1
2009
821
0.010
Why?
Animals
2
2020
62031
0.010
Why?
Outpatients
1
2006
462
0.010
Why?
Cyclooxygenase 2
1
2005
495
0.010
Why?
Reproduction
1
2005
278
0.010
Why?
Mothers
1
2006
416
0.010
Why?
Genome, Human
1
2010
1885
0.010
Why?
Administration, Oral
1
2006
1609
0.010
Why?
Patient Compliance
1
2006
678
0.010
Why?
Radiotherapy Dosage
1
2010
4001
0.010
Why?
Risk
1
2006
1940
0.010
Why?
Epithelium
1
2003
781
0.010
Why?
Infant, Newborn
1
2014
8694
0.010
Why?
Recurrence
1
2009
4875
0.010
Why?
Practice Guidelines as Topic
1
2010
2394
0.010
Why?
Suction
1
2000
121
0.010
Why?
Vascular Surgical Procedures
1
2004
621
0.010
Why?
Blood Vessel Prosthesis Implantation
1
2004
588
0.010
Why?
Meta-Analysis as Topic
1
1999
273
0.010
Why?
Polymorphism, Single Nucleotide
1
2010
4646
0.010
Why?
Gene Expression Profiling
1
2010
5141
0.010
Why?
Infant
1
2014
13982
0.010
Why?
Costs and Cost Analysis
1
1999
310
0.010
Why?
Multivariate Analysis
1
2004
4326
0.010
Why?
Enzyme Inhibitors
1
2003
1946
0.010
Why?
Mice
1
2016
35586
0.010
Why?
Cell Line, Tumor
1
2006
14833
0.010
Why?
SUN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (507)
Explore
_
Co-Authors (92)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_